We’re counting down the days until the best VIVA conference ever. VIVA 16—THE Global Education Course for Vascular Medicine and Intervention—kicks off in just 27 days. To mark the number of days remaining until vascular medicine specialists and their teams join us in Las Vegas for 5 days packed with multispecialty education, we’re celebrating 27 reasons to attend VIVA 16 below.
Reasons 1-16, the ground-breakers:
16 Late-Breaking Trial Presentations
VIVA 16 is already breaking records, including the unrivaled number of late-breaking trial submissions that the Abstracts Review Committee received from investigators around the globe. VIVA 16 will feature 16 late-breaking clinical trials, providing attendees with new, globally significant data that will advance treatment of vascular diseases. Hear it first, here at VIVA!
6 Live Case Sessions
Our signature focus on real-time, case-based education continues at VIVA 16. You’ll watch as experts from around the world perform some of their most challenging cases. Direct your comments and questions to the operators themselves or the on-site moderators who will be critiquing each case along with you.
Reasons 23 & 24: access VIVA's newest educational innovation, CLI and Aortic Focus Sessions! VIVA Focus sessions deliver a full day of in-depth scientific presentations, case reviews, comprehensive panel discussions and opportunities for interaction with faculty experts. This year’s VIVA Focus sessions on Sunday, September 18, are—
Aortic Armageddon: Examining all of the aortic essentials, from the arch to the iliac bifurcation.
Critical Limb Ischemia: Covering all facets of CLI, including diagnostic testing, therapeutic alternatives, advanced endovascular techniques, emerging strategies and new data.
3 Hands-On Workshops
More reasons to attend VIVA? Get live training on the latest devices that are transforming vascular interventions at theseHands-On Workshops: Atherectomy, Percutaneous Thrombectomy, and Vena Cava Filters.
VIVA and its Board of Directors are often mentioned in trade and consumer coverage of vascular conditions and therapies. eVIVA is pleased to share these media highlights:
